Eligard and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Eligard (leuprolide acetate), especially for people who are male, 10-19 old, also take Gabapentin, and have Back pain.

The phase IV clinical study analyzes which people have Weight loss when taking Eligard. It is created by eHealthMe based on reports of 44,585 people who have side effects when taking Eligard from the FDA, and is updated regularly.

What is Eligard?

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. eHealthMe is studying from 44,652 Eligard users. Check the latest studies of Eligard.

What is Weight loss?

Weight loss is found to be associated with 1,457 drugs and 2,291 conditions by eHealthMe. Check the latest studies of Weight loss.

On May, 23, 2026

44,585 people reported to have side effects when taking Eligard.
Among them, 60 people (0.13%) have Weight loss.

Among these 60 people:

What is the gender of people who have Weight loss when taking Eligard? *

female: 1.89 %
male: 98.11 %

What is the age of people who have Weight loss when taking Eligard? *

What are other drugs people take besides Eligard? *

What are other side effects people have besides Weight loss? *

Epidural Lipomatosis (excessive accumulation of fat within the epidural space -brain): 51 people, 85.00%
Respiratory Depression (respiration has a rate below 12 breaths): 51 people, 85.00%
Drug Dependence: 51 people, 85.00%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 51 people, 85.00%
Drug Ineffective: 45 people, 75.00%
Child Abuse: 42 people, 70.00%
Victim Of Child Abuse: 22 people, 36.67%
Tenderness (pain or discomfort when an affected area is touched): 11 people, 18.33%
Hot Flush (sudden feelings of heat): 4 people, 6.67%
Insomnia (sleeplessness): 3 people, 5.00%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 51 people, 85.00%
Pain: 51 people, 85.00%
Itching: 51 people, 85.00%
Constipation: 51 people, 85.00%
Back Pain: 51 people, 85.00%
Sleep Disorder: 49 people, 81.67%
Muscle Spasms (muscle contraction): 48 people, 80.00%
Child Abuse: 47 people, 78.33%
Precocious Puberty: 10 people, 16.67%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eligard and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eligard:

Eligard (44,652 reports)

Weight loss treatments and more:

Weight loss (62,430 reports)

Browse all side effects of Eligard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,457 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,291 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Eligard) and Eligard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.